Liver Damage and Impaired Coagulation in COVID-19 Patients: A Case Series

被引:2
|
作者
Abenavoli, Ludovico [1 ]
Aquila, Isabella [2 ]
Sacco, Matteo Antonio [2 ]
Scarlata, Giuseppe Guido Maria [1 ]
Procopio, Anna Caterina [1 ]
Boccuto, Luigi [3 ]
Scarpellini, Emidio [4 ]
Greco, Marta [1 ]
Foti, Daniela Patrizia [5 ]
Ricci, Pietrantonio [2 ]
Luzza, Francesco [1 ]
机构
[1] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Viale Europa, I-88100 Catanzaro, Italy
[2] Magna Graecia Univ Catanzaro, Inst Legal Med, Dept Med & Surg Sci, Viale Europa, I-88100 Catanzaro, Italy
[3] Clemson Univ, Coll Behav Social & Hlth Sci, Sch Nursing, Healthcare Genet & Genom Doctoral Program, Clemson, SC 29631 USA
[4] Katholieke Univ Leuven, Gasthuisberg Univ Hosp, Translationeel Onderzoek Gastroenterol Aandoeninge, Herestr 49, B-3000 Leuven, Belgium
[5] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Viale Europa, I-88100 Catanzaro, Italy
关键词
SARS-CoV-2; histology; liver disease; inflammation; vascular disease; SARS-COV-2; FAILURE;
D O I
10.3390/diseases11040141
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has generated an unprecedented challenge for healthcare systems worldwide. Currently, the scientific community wonders if liver injury in patients suffering from severe forms is a direct consequence of the virus or secondary manifestations of systemic inflammation. The liver plays an essential role in the development of the inflammatory storm typical of this disease, and its involvement is associated with worse clinical outcomes and a higher risk of morbidity and mortality from Coronavirus disease 2019 (COVID-19). Methods: Ten patients suffering from severe COVID-19 disease who died between January 2020 and December 2021 were included in the present analysis. These subjects underwent a post mortem examination with a focused evaluation of the hepatic injury. Also, several laboratory parameters have been evaluated, with a primary focus on prothrombin time, partial thromboplastin time, fibrinogen, antithrombin III, and D-dimers to detect coagulative changes. Results: The main cause of death was represented by pulmonary thromboembolism events (50%). The analysis of coagulation laboratory parameters and liver biomarkers revealed a statistically significant rise in aPTT and ALP, and a decrease in albumin, when comparing the blood value at admission and death. We also found high levels of D-dimers in most of the subjects at the time of hospitalization. Interestingly, the post mortem analysis of the liver showed ample morphologic variability, with several disease features. In detail, the liver histology revealed the following: the presence of a variable degree of micro- and macrovacuolar steatosis, inflammation (also, hepato-cholangitis), and variable fibrosis. Of mention, we were also able to detect organized fibrinous material. Conclusions: Our results indicate that in subjects with a severe form of COVID-19, liver disease is related to changes in coagulative and fibrinolytic pathways. In particular, we noted low fibrinogen levels and high D-dimer levels with histological liver findings. Our data suggest that fibrinogen and D-dimers may be used as prognostic markers to detect the severity of liver disease in patients with COVID-19. Finally, we underline the crucial role of coagulation balance in subjects with severe forms of COVID-19.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Massive intraperitoneal hemorrhage in patients with COVID-19: a case series
    Reisi-Vanani, Vahid
    Lorigooini, Zahra
    Dayani, Mohamad Ali
    Mardani, Mehrandokht
    Rahmani, Fereidoun
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (01) : 338 - 344
  • [42] Case Series: COVID-19 in African American Patients With Sarcoidosis
    Manansala, Michael
    Ascoli, Christian
    Alburquerque, Ana Goico
    Perkins, David
    Mirsaedi, Mehdi
    Finn, Patricia
    Sweiss, Nadera J.
    [J]. FRONTIERS IN MEDICINE, 2020, 7
  • [43] Charismatic Trends in COVID-19 Patients in Pakistan: A Case Series
    Rehan, Muhammad Awais
    Waheed, Amir
    Iqbal, Momin
    Javed, Ali
    Khalid, Shahid R.
    Shabbir, Adnan
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [44] Challenges of diagnosis of COVID-19 in trauma patients: A case series
    Sabetian, Golnar
    Feiz, Farnia
    Shakibafard, Alireza
    Fard, Hossein Abdolrahimzadeh
    Sefidbakht, Sepideh
    Jafari, Seyed Hamed
    Abbasi, HamidReza
    Zare, Masoomeh
    Roudgari, Amir
    Zand, Farid
    Masjedi, Mansoor
    Paydar, Shahram
    [J]. TRAUMA-ENGLAND, 2021, 23 (03): : 218 - 229
  • [45] The Profile of COVID-19 in Patients with Autoimmune Disease: A Case Series
    Djoerban, Zubairi
    Alkaff, Muhammad
    Priantono, Dimas
    Waluyo, Dyah Agustina
    Marsigit, Jessica
    Noor, Chairina Azyka
    Ichsan, Oemar
    Yonathan, Kevin
    Aisyah, Matdoan Rifikah
    William, Andy
    Rahmah, Uva
    Permatasar, Wahyu
    [J]. ACTA MEDICA INDONESIANA, 2022, 54 (04) : 595 - 602
  • [46] EEG Findings in COVID-19 Positive Patients: A Case Series
    Menon, Uma
    Fine, Lauren
    Chimakurthy, Anil
    Khan, Fawad
    Ramsay, Eugene
    [J]. NEUROLOGY, 2021, 96 (15)
  • [47] Intraparenchymal hemorrhage in Filipino patients with covid-19; a case series
    Arcenas, John Elmer
    Macalintal, Vincent
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [48] Pneumomediastinum following intubation in COVID-19 patients: a case series
    Wali, A.
    Rizzo, V.
    Bille, A.
    Routledge, T.
    Chambers, A. J.
    [J]. ANAESTHESIA, 2020, 75 (08) : 1076 - 1081
  • [49] Xerostomia (dry mouth) in patients with COVID-19: a case series
    Fathi, Yaser
    Hoseini, Elaheh Ghasemzadeh
    Atoof, Fatemeh
    Mottaghi, Reza
    [J]. FUTURE VIROLOGY, 2021, 16 (05) : 315 - 319
  • [50] Case Series of Myasthenia Gravis patients with COVID-19 infection
    Suri, Ritika
    Chandok, Arun
    Sripathi, Naganand
    Grover, Kavita
    [J]. NEUROLOGY, 2021, 96 (15)